Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Dec;78(6):1427–1431. doi: 10.1172/JCI112731

alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.

R W Carrell
PMCID: PMC423882  PMID: 3537008

Full text

PDF
1427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banda M. J., Clark E. J., Werb Z. Regulation of alpha 1 proteinase inhibitor function by rabbit alveolar macrophages. Evidence for proteolytic rather than oxidative inactivation. J Clin Invest. 1985 Jun;75(6):1758–1762. doi: 10.1172/JCI111887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bathurst I. C., Errington D. M., Foreman R. C., Judah J. D., Carrell R. W. Human Z alpha 1-antitrypsin accumulates intracellularly and stimulates lysosomal activity when synthesised in the Xenopus oocyte. FEBS Lett. 1985 Apr 22;183(2):304–308. doi: 10.1016/0014-5793(85)80798-5. [DOI] [PubMed] [Google Scholar]
  3. Bathurst I. C., Stenflo J., Errington D. M., Carrell R. W. Translation and processing of normal (PiMM) and abnormal (PiZZ) human alpha 1-antitrypsin. FEBS Lett. 1983 Mar 21;153(2):270–274. doi: 10.1016/0014-5793(83)80622-x. [DOI] [PubMed] [Google Scholar]
  4. Bathurst I. C., Travis J., George P. M., Carrell R. W. Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver. FEBS Lett. 1984 Nov 19;177(2):179–183. doi: 10.1016/0014-5793(84)81279-x. [DOI] [PubMed] [Google Scholar]
  5. Bhan A. K., Grand R. J., Colten H. R., Alper C. A. Liver in alpha1-antitrypsin deficiency: morphologic observations and in vitro synthesis of alpha1-antitrypsin. Pediatr Res. 1976 Jan;10(1):35–40. doi: 10.1203/00006450-197601000-00007. [DOI] [PubMed] [Google Scholar]
  6. Brower M. S., Harpel P. C. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. J Biol Chem. 1982 Aug 25;257(16):9849–9854. [PubMed] [Google Scholar]
  7. Carp H., Janoff A. In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes. J Clin Invest. 1979 Apr;63(4):793–797. doi: 10.1172/JCI109364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carp H., Janoff A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis. 1978 Sep;118(3):617–621. doi: 10.1164/arrd.1978.118.3.617. [DOI] [PubMed] [Google Scholar]
  9. Carrell R. W., Jeppsson J. O., Laurell C. B., Brennan S. O., Owen M. C., Vaughan L., Boswell D. R. Structure and variation of human alpha 1-antitrypsin. Nature. 1982 Jul 22;298(5872):329–334. doi: 10.1038/298329a0. [DOI] [PubMed] [Google Scholar]
  10. Carrell R. W., Owen M. C. Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature. 1985 Oct 24;317(6039):730–732. doi: 10.1038/317730a0. [DOI] [PubMed] [Google Scholar]
  11. Cochrane C. G., Spragg R., Revak S. D. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest. 1983 Mar;71(3):754–761. doi: 10.1172/JCI110823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Courtney M., Jallat S., Tessier L. H., Benavente A., Crystal R. G., Lecocq J. P. Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis. Nature. 1985 Jan 10;313(5998):149–151. doi: 10.1038/313149a0. [DOI] [PubMed] [Google Scholar]
  13. Cox D. W., Woo S. L., Mansfield T. DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature. 1985 Jul 4;316(6023):79–81. doi: 10.1038/316079a0. [DOI] [PubMed] [Google Scholar]
  14. Duswald K. H., Jochum M., Schramm W., Fritz H. Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery. 1985 Nov;98(5):892–899. [PubMed] [Google Scholar]
  15. Egbring R., Schmidt W., Fuchs G., Havemann K. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood. 1977 Feb;49(2):219–231. [PubMed] [Google Scholar]
  16. Eriksson S., Hägerstrand I. Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency. Acta Med Scand. 1974 Jun;195(6):451–458. doi: 10.1111/j.0954-6820.1974.tb08170.x. [DOI] [PubMed] [Google Scholar]
  17. Errington D. M., Bathurst I. C., Carrell R. W. Human alpha 1-antitrypsin expression in Xenopus oocytes. Secretion of the normal (PiM) and abnormal (PiZ) forms. Eur J Biochem. 1985 Dec 2;153(2):361–365. doi: 10.1111/j.1432-1033.1985.tb09311.x. [DOI] [PubMed] [Google Scholar]
  18. Errington D. M., Bathurst I. C., Janus E. D., Carrell R. W. In vitro synthesis of M and Z forms of human alpha 1-antitrypsin. FEBS Lett. 1982 Nov 1;148(1):83–86. doi: 10.1016/0014-5793(82)81247-7. [DOI] [PubMed] [Google Scholar]
  19. George P. M., Vissers M. C., Travis J., Winterbourn C. C., Carrell R. W. A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease. Lancet. 1984 Dec 22;2(8417-8418):1426–1428. doi: 10.1016/s0140-6736(84)91623-4. [DOI] [PubMed] [Google Scholar]
  20. Hodges J. R., Millward-Sadler G. H., Barbatis C., Wright R. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med. 1981 Mar 5;304(10):557–560. doi: 10.1056/NEJM198103053041001. [DOI] [PubMed] [Google Scholar]
  21. Hultcrantz R., Mengarelli S. Ultrastructural liver pathology in patients with minimal liver disease and alpha 1-antitrypsin deficiency: a comparison between heterozygous and homozygous patients. Hepatology. 1984 Sep-Oct;4(5):937–945. doi: 10.1002/hep.1840040526. [DOI] [PubMed] [Google Scholar]
  22. Hunt L. T., Dayhoff M. O. A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor. Biochem Biophys Res Commun. 1980 Jul 31;95(2):864–871. doi: 10.1016/0006-291x(80)90867-0. [DOI] [PubMed] [Google Scholar]
  23. Janoff A., Chan S. K., Abboud R. T., Richter A., Fera T., Johal S. Is alpha 1-protease inhibitor inactivated by smoking? Science. 1984 May 18;224(4650):755–756. [PubMed] [Google Scholar]
  24. Janus E. D., Phillips N. T., Carrell R. W. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet. 1985 Jan 19;1(8421):152–154. doi: 10.1016/s0140-6736(85)91916-6. [DOI] [PubMed] [Google Scholar]
  25. Jochum M., Lander S., Heimburger N., Fritz H. Effect of human granulocytic elastase on isolated human antithrombin III. Hoppe Seylers Z Physiol Chem. 1981 Feb;362(2):103–112. doi: 10.1515/bchm2.1981.362.1.103. [DOI] [PubMed] [Google Scholar]
  26. Johnson D., Travis J. Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. J Biol Chem. 1978 Oct 25;253(20):7142–7144. [PubMed] [Google Scholar]
  27. Johnson D., Travis J. The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem. 1979 May 25;254(10):4022–4026. [PubMed] [Google Scholar]
  28. Kress L. F., Kurecki T., Chan S. K., Laskowski M., Sr Characterization of the inactive fragment resulting from limited proteolysis of human alpha1-proteinase inhibitor by Crotalus adamanteus proteinase II. J Biol Chem. 1979 Jun 25;254(12):5317–5320. [PubMed] [Google Scholar]
  29. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand. 1978;204(5):345–351. doi: 10.1111/j.0954-6820.1978.tb08452.x. [DOI] [PubMed] [Google Scholar]
  30. Lieberman J. Elastase, collagenase, emphysema, and alpha1-antitrypsin deficiency. Chest. 1976 Jul;70(1):62–67. doi: 10.1378/chest.70.1.62. [DOI] [PubMed] [Google Scholar]
  31. Loebermann H., Tokuoka R., Deisenhofer J., Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531–557. [PubMed] [Google Scholar]
  32. Morihara K., Tsuzuki H., Harada M., Iwata T. Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase. J Biochem. 1984 Mar;95(3):795–804. doi: 10.1093/oxfordjournals.jbchem.a134671. [DOI] [PubMed] [Google Scholar]
  33. Muensch H. A., Maslow W. C. Liver disease and alpha 1-antitrypsin deficiency. Lancet. 1982 Oct 30;2(8305):983–984. doi: 10.1016/s0140-6736(82)90179-9. [DOI] [PubMed] [Google Scholar]
  34. Munro S., Pelham H. What turns on heat shock genes? Nature. 1985 Oct 10;317(6037):477–478. doi: 10.1038/317477a0. [DOI] [PubMed] [Google Scholar]
  35. Owen M. C., Brennan S. O., Lewis J. H., Carrell R. W. Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med. 1983 Sep 22;309(12):694–698. doi: 10.1056/NEJM198309223091203. [DOI] [PubMed] [Google Scholar]
  36. Perlmutter D. H., Cole F. S., Kilbridge P., Rossing T. H., Colten H. R. Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. Proc Natl Acad Sci U S A. 1985 Feb;82(3):795–799. doi: 10.1073/pnas.82.3.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Perlmutter D. H., Kay R. M., Cole F. S., Rossing T. H., Van Thiel D., Colten H. R. The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A. 1985 Oct;82(20):6918–6921. doi: 10.1073/pnas.82.20.6918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Riley J. H., Bathurst I. C., Edbrooke M. R., Carrell R. W., Craig R. K. Alpha 1-antitrypsin and serum albumin mRNA accumulation in normal, acute phase and ZZ human liver. FEBS Lett. 1985 Sep 23;189(2):361–366. doi: 10.1016/0014-5793(85)81056-5. [DOI] [PubMed] [Google Scholar]
  39. Rosenberg S., Barr P. J., Najarian R. C., Hallewell R. A. Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin. Nature. 1984 Nov 1;312(5989):77–80. doi: 10.1038/312077a0. [DOI] [PubMed] [Google Scholar]
  40. Schnebli H. P., Seemüller U., Fritz H., Maschler R., Liersch M., Virca G. D., Bodmer J. L., Snider G. L., Lucey E. C., Stone P. G. Eglin c, a pharmacologically active elastase inhibitor. Eur J Respir Dis Suppl. 1985;139:66–70. [PubMed] [Google Scholar]
  41. Scott G. K., Seow H. F. Further evidence for a cell surface proteinase essential to the growth of cultured fibroblasts. Exp Cell Res. 1985 May;158(1):41–52. doi: 10.1016/0014-4827(85)90429-x. [DOI] [PubMed] [Google Scholar]
  42. Sharp H. L., Bridges R. A., Krivit W., Freier E. F. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med. 1969 Jun;73(6):934–939. [PubMed] [Google Scholar]
  43. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976 Jun 10;294(24):1316–1321. doi: 10.1056/NEJM197606102942404. [DOI] [PubMed] [Google Scholar]
  44. Sveger T., Thelin T. Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening. Acta Paediatr Scand. 1981 Mar;70(2):171–177. doi: 10.1111/j.1651-2227.1981.tb05537.x. [DOI] [PubMed] [Google Scholar]
  45. Travis J., Salvesen G. S. Human plasma proteinase inhibitors. Annu Rev Biochem. 1983;52:655–709. doi: 10.1146/annurev.bi.52.070183.003255. [DOI] [PubMed] [Google Scholar]
  46. Udall J. N., Bloch K. J., Walker W. A. Transport of proteases across neonatal intestine and development of liver disease in infants with alpha-1 antitrypsin deficiency. Lancet. 1982 Jun 26;1(8287):1441–1443. doi: 10.1016/s0140-6736(82)92454-0. [DOI] [PubMed] [Google Scholar]
  47. Weiss S. J., Regiani S. Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites. J Clin Invest. 1984 May;73(5):1297–1303. doi: 10.1172/JCI111332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Westaby S. Complement and the damaging effects of cardiopulmonary bypass. Thorax. 1983 May;38(5):321–325. doi: 10.1136/thx.38.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES